Boritz Eli, Rapaport Eric L, Campbell Thomas B, Koeppe John R, Wilson Cara C
Department of Immunology, University of Colorado Health Sciences Center, Denver, CO, USA.
Virology. 2007 Apr 25;361(1):34-44. doi: 10.1016/j.virol.2006.10.040. Epub 2006 Dec 13.
We previously detected HIV-1 Gag-specific CD4+ T cells recognizing reference strain viral epitopes in subjects with progressive, chronic infection. To test whether these CD4+ T cells persist in vivo by failing to recognize autologous HIV-1 epitopes, we compared autologous plasma HIV-1 p24 nucleotide sequences with targeted HXB.2 strain Gag p24 CD4+ T cell epitopes in nine chronically infected, untreated subjects. In five responding subjects, 10 of 26 HXB.2 strain p24 peptides targeted by CD4+ T cells exactly matched autologous plasma viral sequences. Four subjects with plasma viral loads >100,000 copies/mL had no measurable p24-specific CD4+ T cell responses despite carrying HIV-1 strains that matched HXB.2 sequences at predicted epitopes. These results show that HIV-1-specific CD4+ T cells can persist in chronic HIV-1 infection despite recognition of epitopes present in vivo. However, with high-level in vivo HIV-1 replication, CD4+ T cells targeting autologous HIV-1 may be non-responsive or absent.
我们之前在患有进行性慢性感染的受试者中检测到了识别参考株病毒表位的HIV-1 Gag特异性CD4+ T细胞。为了测试这些CD4+ T细胞是否因无法识别自身HIV-1表位而在体内持续存在,我们将9名未经治疗的慢性感染受试者的自身血浆HIV-1 p24核苷酸序列与靶向的HXB.2株Gag p24 CD4+ T细胞表位进行了比较。在5名有反应的受试者中,CD4+ T细胞靶向的26个HXB.2株p24肽中有10个与自身血浆病毒序列完全匹配。4名血浆病毒载量>100,000拷贝/mL的受试者,尽管携带的HIV-1毒株在预测表位处与HXB.2序列匹配,但未检测到可测量的p24特异性CD4+ T细胞反应。这些结果表明,尽管识别了体内存在的表位,但HIV-1特异性CD4+ T细胞仍可在慢性HIV-1感染中持续存在。然而,在体内HIV-1高水平复制的情况下,靶向自身HIV-1的CD4+ T细胞可能无反应或不存在。